217691 Sigma-AldrichCDC25 Phosphatase Inhibitor I, BN82002 - CAS 396073-89-5 - Calbiochem
The CDC25 Phosphatase Inhibitor I, BN82002, also referenced under CAS 396073-89-5, controls the biological activity of CDC25 Phosphatase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
More>> The CDC25 Phosphatase Inhibitor I, BN82002, also referenced under CAS 396073-89-5, controls the biological activity of CDC25 Phosphatase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Less<<Synonyms: N-(2-Hydroxy-3-methoxy-5-dimethylamino)benzyl, Nʹ-(2-(4-nitrophenethyl)), Nʹʹ-methylamine, PTP Inhibitor XX
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
396073-89-5 | C₁₉H₂₅N₃O₄ |
Products
Catalogue Number | Packaging | Qty/Pack | |
---|---|---|---|
217691-5MG | Plastová ampulka | 5 mg |
References | |
---|---|
References | Brezak, M.C., et al. 2004. Cancer Res. 64, 3320. |
Product Information | |
---|---|
CAS number | 396073-89-5 |
ATP Competitive | N |
Form | Red to dark red solid |
Hill Formula | C₁₉H₂₅N₃O₄ |
Chemical formula | C₁₉H₂₅N₃O₄ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
217691-5MG | 04055977202281 |
Documentation
CDC25 Phosphatase Inhibitor I, BN82002 - CAS 396073-89-5 - Calbiochem MSDS
Title |
---|
CDC25 Phosphatase Inhibitor I, BN82002 - CAS 396073-89-5 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
217691 |
References
Reference overview |
---|
Brezak, M.C., et al. 2004. Cancer Res. 64, 3320. |